Plain-English translation of NCT07667192 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry—not a clinical trial testing a new drug—that gathers information from patients with gynecologic cancers that have returned after previous treatment. Doctors are studying what happens when patients receive repeat radiation therapy or other focused treatments aimed at destroying remaining cancer in the pelvis. By collecting data from many patients across multiple hospitals, researchers hope to understand which approaches work best and which side effects patients are most likely to experience.
When gynecologic cancers come back after initial treatment, repeat radiation therapy and other local ablative strategies may offer hope—but doctors don't yet have clear information about how well these approaches work in real-world settings, or what long-term complications patients may face. This registry aims to fill that gap by gathering detailed outcome data from many patients over time.
You likely qualify if…
You likely don't qualify if…
Participation is flexible and does not interfere with your regular cancer care. Depending on when you join, you may have your medical records and prior treatment information reviewed by the research team, and your doctors may ask permission to collect information about your imaging scans, treatment response, side effects, and long-term outcomes as you continue regular follow-up visits. Some patients will have already started treatment before joining, while others may enroll before or at the time their repeat radiation therapy is planned. Your own treatment plan is chosen by your doctors—the registry simply tracks what happens over time.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Poland